RT Journal Article
SR Electronic
T1 Drs. Bessette and Kinch reply
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.220909
DO 10.3899/jrheum.220909
A1 Louis Bessette
A1 Cassandra D.  Kinch
YR 2022
UL http://www.jrheum.org/content/early/2022/10/10/jrheum.220909.abstract
AB We thank Dr. Tchetina for their interest in our article,1 and we appreciate the opportunity to respond to their Letter to the Editor.2 In the letter and their recent publication, Tchetina et al describe the utility of gene expression analyses using peripheral blood mononuclear cells (PBMCs) from patients with rheumatoid arthritis (RA) to predict clinical response to tofacitinib (TOF).2,3